Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities Various Arab news Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities AETOS Wire 11 May، 2023 SALT LAKE CITY and TORONTO and MONTRÉAL — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding... Read More Read more about Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
